Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $71,184 - $82,758
140 Added 3.78%
3,840 $2 Million
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $1.5 Million - $1.69 Million
2,800 Added 311.11%
3,700 $2.13 Million
Q4 2022

Feb 13, 2023

SELL
$484.71 - $571.37 $504,098 - $594,224
-1,040 Reduced 53.61%
900 $495,000
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $613,699 - $731,432
1,210 Added 165.75%
1,940 $984,000
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $382,520 - $470,791
730 New
730 $431,000
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $304,542 - $369,362
-700 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $804,409 - $1.06 Million
-2,923 Reduced 80.68%
700 $254,000
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $924,951 - $1.23 Million
3,623 New
3,623 $1.03 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $257,510 - $295,550
-1,000 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$212.17 - $273.72 $318,255 - $410,580
-1,500 Reduced 60.0%
1,000 $264,000
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $521,175 - $629,950
2,500 New
2,500 $559,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $203B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Stamos Capital Partners, L.P. Portfolio

Follow Stamos Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.